Why is NVIDIA stock rallying today?

NVIDIA shares rose 3.8% after the company pushed back on reports that its Kyber NVL144 rack system (for 144 Rubin Ultra chips) would be delayed to 2028, saying the platform remains on schedule. Goldman highlighted the stock’s ~21.7x forward P/E as attractively priced versus the S&P 500 and below NVIDIA’s own 5-year average, while noting hyperscaler AI capex growth isn’t fully reflected yet. The semis sector also got a tailwind from Apple’s chip-supply agreement with Broadcom valued at over $30B, helping offset a risk-off macro tape tied to U.S.-Iran escalation and higher oil prices.

Analysis

The key mechanism here is not just relief on one product timeline; it is a reset of perceived execution risk for the entire AI rack build-out. If the market believes NVDA can keep its platform cadence intact, the earnings multiple can stay anchored to forward growth rather than being discounted for a supply-chain stumble, which is why the rebound was stronger than the tape. The near-term winners are NVDA and, secondarily, the AI infrastructure complex tied to hyperscaler capex; the losers are the names that were implicitly trading on NVDA delay-driven share gains, especially AMD, where the burden of proof shifts back to actual product share rather than timing noise.

The China H200 signal matters more as an option on revenue than as an immediate P&L step-up: limited approvals reduce the probability of a full China reset, but they also prevent the market from writing off that channel entirely. That creates upside convexity for NVDA over 1-3 months if licensing broadens, but it is not enough to change the structural picture unless volumes become repeatable. By contrast, AVGO’s Apple deal is cleaner duration: committed spend with less headline volatility, making it a better expression of secular infrastructure demand than a pure China-policy bet.

Contrarian view: the consensus may be underpricing how much of today’s move is just short-covering after a crowded delay narrative, especially with Fed uncertainty and oil-driven multiple pressure still hanging over the tape. If hyperscaler capex commentary softens over the next earnings cycle, NVDA can hand back a meaningful portion of this squeeze even with the roadmap intact. The thesis is falsified if Rubin Ultra timing slips again, if China approvals remain token-sized, or if forward gross margin/guidance fails to re-accelerate despite the repaired sentiment.

Key Decisions for Investors

• Long NVDA into any pullback over the next 1-3 weeks; target is continued multiple recovery as execution risk gets de-risked. Falsify if management/industry chatter reintroduces schedule slippage or if the next guide does not show re-acceleration.
• Pair trade: long NVDA / short AMD for 1-3 months. AMD’s relative bull case depended on a delay narrative that has now been weakened; risk is a sudden share-credibility event or stronger-than-expected AMD AI bookings.
• Add AVGO on weakness for a 6-18 month hold; the Apple supply agreement is a cleaner cash-flow signal than the NVDA/China headlines. Risk/reward is favorable if AI infrastructure capex remains firm, but watch for any Apple concentration discount.
• Avoid chasing GOOGL on the China narrative; the market may have overestimated any share-share transfer from an NVDA delay. If Google TPU/AI infrastructure spending is still accelerating into earnings, revisit, otherwise the setup looks less compelling than NVDA/AVGO.
• Set a tactical alert on the semiconductor group: if SOX/SMH can hold gains while oil stays elevated, this becomes a relative-strength long versus cyclicals. If oil spikes further and rates reprice higher, expect multiple compression to cap upside quickly.